Sports Med. 2002;32(13):851-65.
Extracorporeal shockwave therapy: a review.
Source http://www.ncbi.nlm.nih.gov/pubmed/12392445
Sport Medicine Centre, University of Calgary, Calgary, Alberta, Canada.Abstract
Extracorporeal
shockwave therapy (ESWT) has been in use for the treatment of
tendinopathies since the early 1990s. The exact mechanism by which ESWT
relieves tendon-associated pain is not known; however, there is an
increasing body of literature that suggests that it can be an effective
therapy for patients who have had repeated nonsurgical treatment
failures. The highest strength of evidence is shown in randomised
controlled trials, of which there are a small number. Reported results
for tendinopathies of the shoulder, elbow and heel have shown consistent
positive results in favour of ESWT over placebo ESWT in individuals who
have failed conservative therapy. These studies provide strong evidence
for ESWT as an effective therapy for the treatment of chronic
treatment-resistant tendinopathies. There is still much debate over
several issues surrounding ESWT that have not been adequately addressed
by the literature: high- versus low-energy ESWT, shockwave dosage and
number of sessions required for a therapeutic effect. Further research
is needed to ascertain the most beneficial protocol for patient care.
- PMID:
- 12392445
- [PubMed - indexed for MEDLINE]
No comments:
Post a Comment